Company
Atara Biotherapeutics, Inc.
ATRA · CIK 0001604464
Purchase of 104,166 shares at $9.60 per share.
Reporting Person Cherry Brian N · Transaction Code P
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0000905148-26-004085 · filed 2026-09-04 · View filing →
Sale of 5,062 shares at $8.0764 per share.
Reporting Person Nguyen AnhCo · Officer Title President and CEO · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 26, 2026FILED +9 DAYS
Source: SEC Form 4 · 0000905148-26-003960 · filed 2026-08-26 · View filing →